IDEXX LABORATORIES Files 8-K on Financials
Ticker: IDXX · Form: 8-K · Filed: Nov 3, 2025 · CIK: 874716
| Field | Detail |
|---|---|
| Company | Idexx Laboratories Inc /De (IDXX) |
| Form Type | 8-K |
| Filed Date | Nov 3, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.10 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, 8-k
TL;DR
IDEXX LABS filed an 8-K on Nov 3, 2025, detailing financial results and condition.
AI Summary
On November 3, 2025, IDEXX LABORATORIES, INC. filed an 8-K report with the SEC. The filing pertains to the company's results of operations and financial condition, as well as financial statements and exhibits. The report was filed in Delaware and its principal executive offices are located at One IDEXX Drive, Westbrook, Maine.
Why It Matters
This 8-K filing provides an update on IDEXX Laboratories' financial performance and condition, which is crucial information for investors to assess the company's health and future prospects.
Risk Assessment
Risk Level: low — This is a routine 8-K filing reporting financial information and does not indicate any unusual or high-risk events.
Key Players & Entities
- IDEXX LABORATORIES, INC. (company) — Registrant
- November 3, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- One IDEXX Drive, Westbrook, Maine 04092 (address) — Address of principal executive offices
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on the 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits' of IDEXX LABORATORIES, INC.
When was the earliest event reported in this filing?
The earliest event reported in this filing occurred on November 3, 2025.
In which state is IDEXX LABORATORIES, INC. incorporated?
IDEXX LABORATORIES, INC. is incorporated in Delaware.
What is the principal executive office address for IDEXX LABORATORIES, INC.?
The principal executive office address for IDEXX LABORATORIES, INC. is One IDEXX Drive, Westbrook, Maine 04092.
What is the SEC file number for IDEXX LABORATORIES, INC.?
The SEC file number for IDEXX LABORATORIES, INC. is 000-19271.
Filing Stats: 558 words · 2 min read · ~2 pages · Grade level 10.9 · Accepted 2025-11-03 06:34:17
Key Financial Figures
- $0.10 — ange on whichregistered Common Stock, $0.10 par value per share IDXX NASDAQ Glo
Filing Documents
- tm2530045d1_8k.htm (8-K) — 34KB
- tm2530045d1_ex99-1.htm (EX-99.1) — 542KB
- tm2530045d1_8kimg001.jpg (GRAPHIC) — 7KB
- tm2530045d1_ex99-1sp1img001.jpg (GRAPHIC) — 3KB
- 0001104659-25-105185.txt ( ) — 802KB
- idxx-20251103.xsd (EX-101.SCH) — 3KB
- idxx-20251103_lab.xml (EX-101.LAB) — 33KB
- idxx-20251103_pre.xml (EX-101.PRE) — 22KB
- tm2530045d1_8k_htm.xml (XML) — 3KB
02 Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition. On November 3, 2025, IDEXX Laboratories, Inc. (the "Company") announced its financial results for the quarter ended September 30, 2025. The full text of the press release issued in connection with the announcement is furnished as Exhibit 99.1 to this Current Report on Form 8-K. In accordance with general instructions to Form 8-K, the information in this Form 8-K and the Exhibit 99.1 attached hereto is being furnished under Item 2.02 and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise 1933 or the Exchange Act, except as expressly set forth by specific reference in such a filing.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d)Exhibits The following exhibit relating to Item 2.02 shall be deemed to be furnished, and not filed. Exhibit No. Description of Exhibit 99.1 Press Release entitled "IDEXX Laboratories Announces Third Quarter Results," issued by the Company on November 3, 2025. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 2
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. IDEXX LABORATORIES, INC. Date: November 3, 2025 By: /s/ Andrew Emerson Andrew Emerson Executive Vice President, Chief Financial Officer and Treasurer 3